RICKY PAMPHILE: Open Payments
NPI 1356977193 · BOSTON, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,720 in 9 payments from 6 companies in 2025. Trend: 2023 $24 · 2024 $231 · 2025 $1,720
Consulting: $1,014Food & beverage: $706
| Company | Payments | Amount |
|---|---|---|
| Insulet Corporation | 3 | $1,140 |
| Medtronic, Inc. | 1 | $151 |
| Tandem Diabetes Care, Inc. | 1 | $150 |
| Sequel Med Tech, LLC | 1 | $119 |
| CeQur Corporation | 1 | $117 |
| Novo Nordisk Inc | 2 | $44 |
Products named: OMNIPOD, MINIMED 780G, t:slim X2 Insulin Pump with Control-IQ, TWIIST, CeQur Simplicity, Ozempic.
Industry payments across MA — which companies pay providers there.
